Bezafibrate (drug) ( DrugBank: Bezafibrate )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 316 | カルニチン回路異常症 | 1 |
316. カルニチン回路異常症
臨床試験数 : 4 / 薬物数 : 10 - (DrugBank : 4) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 11
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00336167 (ClinicalTrials.gov) | June 2006 | 9/6/2006 | Bezafibrate Trial in CPT2 Deficiency | Clinical Trial on the Effect of Bezafibrate in the Muscular Form of Carnitine Palmitoyltransferase 2 Deficiency | Carnitine Palmitoyl Transferase 2 Deficiency | Drug: bezafibrate (drug) | Assistance Publique - Hôpitaux de Paris | Association Française contre les Myopathies (AFM), Paris;Institut National de la Santé Et de la Recherche Médicale, France | Recruiting | 18 Years | N/A | Both | 12 | Phase 3 | France |